NCT05735262 is a NA clinical trial of active iTBS in Autism Spectrum Disorder, sponsored by Changping Laboratory.

Who is sponsoring NCT05735262?

NCT05735262 is sponsored by Changping Laboratory.

What drugs are being tested in NCT05735262?

Interventions in NCT05735262: active iTBS, sham iTBS.

What condition does NCT05735262 study?

NCT05735262 studies Autism Spectrum Disorder.

Is NCT05735262 still recruiting?

NCT05735262 is currently status unknown. Last updated 30 May 2023.

Last reviewed 2023-05-30 · How we verify

NCT05735262

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

pBFS Guided Precision Neuromodulation Treatment for ASD

Status unknown NA Last updated 30 May 2023

What this trial tests

NA trial testing active iTBS in Autism Spectrum Disorder in 100 participants. Status unknown.

Timeline

7 March 2023

Primary endpoint
1 March 2024

1 January 2025

Quick facts

Lead sponsor	Changping Laboratory
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	100
Start date	7 March 2023
Primary completion	1 March 2024
Estimated completion	1 January 2025
Sites	1 location across China

Drugs / interventions tested

active iTBS
sham iTBS

Conditions studied

Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →

Sponsor

Changping Laboratory

Who can join

Adults 6 to 30, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the neuromodulation (i.e., iTBS) effectiveness for treating autism spectrum disorder (ASD) by targeting at the pBFS-guided executive function brain network or social brain network.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of active iTBS

Trials testing the same drug.

NCT06950437 — pBFS Guided aiTBS Over Language Network for ASD Child · NA · recruiting
NCT06031948 — pBFS-guided Noninvasive Neuromodulation for Pre-school Children With ASD · NA · unknown
NCT07515261 — pBFS Guided Neuromodulation Over DMPFC for ASD Treatment: Pilot Study · NA · completed
NCT05607654 — The Mechanisms of Underlying Accelerated Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression · NA · recruiting
NCT05890846 — Precision TMS Treatment Guided by Personalized Brain Functional Sectors (pBFS) for ASD · NA · recruiting

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting

Other Changping Laboratory trials

Trials by the same sponsor.

NCT06350396 — pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression · NA · recruiting
NCT06255535 — pBFS Guided rTMS Over Cognitive Control Network for ASD · NA · recruiting
NCT06255561 — pBFS Guided rTMS Over Different Targets for Treatment-Resistant Depression · NA · unknown
NCT06166082 — Stanford Neuromodulation Therapy (SNT) for the Treatment-Resistant Depression · NA · unknown
NCT06112652 — Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05735262 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Changping Laboratory
Last refreshed: 30 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05735262.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing